Company Filing History:
Years Active: 2013
Title: Sandra Künzle: Innovator in Tumor-Specific Antibodies
Introduction
Sandra Künzle is a prominent inventor based in Zurich, Switzerland. She has made significant contributions to the field of biotechnology, particularly in the development of novel human tumor-specific antibodies. Her work is crucial in advancing cancer treatment options.
Latest Patents
Sandra Künzle holds a patent for a monoclonal human tumor-specific antibody. This patent describes novel human tumor-specific antibodies, as well as fragments, derivatives, and variants that recognize the tumor-associated antigen NY-ESO-1. Additionally, the patent includes pharmaceutical compositions comprising such antibodies and mimics for the treatment of tumors.
Career Highlights
Künzle is affiliated with the University of Zurich, where she conducts her research and development work. Her innovative approach has positioned her as a key figure in the field of cancer immunotherapy.
Collaborations
Sandra collaborates with notable colleagues, including Christoph Esslinger and Irene Abela. Their combined expertise enhances the research efforts at the University of Zurich.
Conclusion
Sandra Künzle's work in developing tumor-specific antibodies represents a significant advancement in cancer treatment. Her contributions are paving the way for new therapeutic options that could improve patient outcomes.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.